Completed

Phase 1
Age: 33Years - 43Years
All Genders
ID00000220

Gradual Vs. Rapid Buprenorphine Detoxification

Led by National Institute on Drug Abuse (NIDA) · Updated on 2005-06-24

N/A

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

N

National Institute on Drug Abuse (NIDA)

Lead Sponsor

U

University of Vermont

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to determine an optimal detoxification dose reduction schedule with buprenorphine.

CONDITIONS

Official Title

Gradual Vs. Rapid Buprenorphine Detoxification - 2

Who Can Participate

Age: 33Years - 43Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

Please contact site for information.

Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

Trial Site Locations

Total: 1 location

1

Treatment Research Center

Burlington, Vermont, United States, 05401

Status Unknown

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

N/A

Model

N/A

Primary Purpose

TREATMENT

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial